Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC)-Reference-Cited by-同舟云学术

Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC)

Published:2018-06-01 Issue:2 Volume:40 Page:173-189
ISSN:0387-821X
Container-title:Journal of UOEH
language:en
Short-container-title:J UOEH

Author:

YONEDA Kazue¹,IMANISHI Naoko¹,ICHIKI Yoshinobu¹,TANAKA Fumihiro¹

Affiliation:

1. Second Department of Surgery (Chest Surgery), School of Medicine, University of Occupational and Environmental Health, Japan.

Publisher

The University of Occupational and Environmental Health, Japan

Subject

Public Health, Environmental and Occupational Health,General Medicine

Link

https://www.jstage.jst.go.jp/article/juoeh/40/2/40_173/_pdf

Reference57 articles.

1. 1. Nakanishi Y (2015): Implementation of modern therapy approaches and research for non-small cell lung cancer in Japan. Respirology 20: 199−208

2. 2. Travis WD, Brambilla E, Nicholson AG et al (2015): The 2015 World Health Organization Classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10: 1243−1260

3. 3. Rudin CM, Ismaila N, Hann CL, Malhotra N, Movsas B, Norris K, Pietanza MC, Ramalingam SS, Turrisi AT 3rd & Giaccone G (2015): Treatment of small-cell lung cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline. J Clin Oncol 33: 4106−4111

4. 4. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J & Johnson DH (2002): Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92−98

5. 5. Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y & Fukuoka M (2007): Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 18: 317−323

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy;Oncology and Therapy;2024-07-22

2. The Construction of a Nomogram Using the Pan-Immune-Inflammation Value Combined with a PILE Score for Immunotherapy Prediction Prognosis in Advanced NSCLC;Cancer Management and Research;2024-07

3. Development of Vogt–Koyanagi–Harada disease-like uveitis during treatment by anti-programmed death-1 antibody: a case report;BMC Ophthalmology;2024-06-07

4. The Comprehensive Characterization of B7-H3 Expression in the Tumor Microenvironment of Lung Squamous Cell Carcinoma: A Retrospective Study;Cancers;2024-06-04

5. Review Deciphering the Potential of Nanotherapeutics in Lung Cancer Management;Current Cancer Drug Targets;2024-03-29